Semaglutide: A Promising Ally Against Alzheimer’s?
In a groundbreaking study, researchers at Case Western Reserve School of Medicine have identified a potential new benefit of semaglutide, a widely used diabetes and weight-loss drug. According to their findings, semaglutide may significantly reduce the risk of Alzheimer’s disease in individuals with type 2 diabetes (T2D), outperforming seven other anti-diabetic medications.
Alzheimer’s disease, a devastating brain disorder that erodes memory and cognitive abilities, affects nearly 7 million Americans aged 65 and older, as reported by the Alzheimer’s Association. Alarmingly, it claims more lives annually than breast and prostate cancer combined.
Published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, the study suggests that T2D patients taking semaglutide had a markedly lower risk of developing Alzheimer’s disease. This trend was consistent across various subgroups, regardless of obesity status, gender, or age.
Semaglutide, a glucagon-like peptide receptor (GLP-1R) agonist, is the active ingredient in popular medications like Wegovy and Ozempic. It works by reducing hunger and regulating blood sugar levels in T2D patients.
Under the leadership of Rong Xu, a professor of biomedical informatics, the research team analyzed three years of electronic health records from nearly one million U.S. patients with T2D. Their statistical approach, which mimicked a randomized clinical trial, revealed that patients prescribed semaglutide had a significantly lower risk of Alzheimer’s compared to those on other anti-diabetic medications.
According to the CDC, Alzheimer’s disease results in approximately 120,000 deaths annually, ranking as the seventh-leading cause of death in the United States.
“This new study provides real-world evidence for semaglutide’s potential impact on Alzheimer’s disease,” Xu stated. “While preclinical research has hinted at its protective effects against neurodegeneration and neuroinflammation, our findings suggest the need for further exploration through randomized clinical trials.”
Despite these promising results, the study’s limitations prevent researchers from drawing definitive causal conclusions. Xu emphasized the importance of continued research into semaglutide’s potential as a treatment for this debilitating condition, encouraging further investigation into alternative drugs.
For more information, please contact Patty Zamora at [email protected].
More Articles
Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!
Nevada has enacted a first‑in‑the‑nation law permitting insurers to sell homeowners policies that exclude wildfire coverage, a move supporters say could help stabilize premiums but critics warn may leave homeowners financially devastated. The policy shift positions Nevada as a testing ground for potential nationwide changes, raising major implications for real estate, mortgage, and insurance professionals as lenders, high‑risk communities, and regulators navigate the evolving landscape.
Tampa Bay’s office sector just delivered its most powerful year in nearly a decade, according to JLL’s Q4 2025 report. With more than 600,000 square feet of positive net absorption, falling vacancies, shrinking inventory, and major tenants like Fisher Investments and GEICO locking in massive leases, the region is emerging as one of the nation’s strongest post‑recovery office markets. The surge in demand for high‑quality space is driving rents up, tightening supply, and setting the stage for continued momentum into 2026.
The Consumer Financial Protection Bureau has proposed new updates to the Nationwide Mortgage Licensing System and Registry, expanding data collection, tightening verification standards, and refreshing record‑retention rules. These changes aim to strengthen background checks, enhance regulatory oversight, and align the system with federal requirements—impacting both current and aspiring mortgage loan originators nationwide.
Nevada has become the first state to let insurers sell homeowners policies that exclude wildfire coverage — a dramatic shift that could reshape insurance pricing across the West. Supporters say the move may lower premiums and spark innovation, while critics warn it could leave homeowners exposed to devastating losses. As regulators and insurers nationwide watch closely, the experiment could have major implications for real estate, mortgages, and insurance markets.
After years of soaring premiums and insurer failures, Florida lawmakers are rolling out a new slate of reforms aimed at finally delivering relief to homeowners. From cracking down on profit‑sharing affiliates to unveiling hidden rate factors and rewarding claim‑free residents, these proposals could reshape the state’s insurance landscape — and bring real savings to property owners and real estate professionals alike.
With traditional CRE lending slowing nationwide, C‑PACE financing is surging to all‑time highs — including a record‑setting $465 million loan for a major D.C. redevelopment. Backed by long repayment terms, fixed rates, and tax‑assessment security, C‑PACE is rapidly becoming a preferred tool for funding energy efficiency, resiliency upgrades, and even large‑scale project recapitalizations. Major players like Nuveen Green Capital and Peachtree Group are driving billions in new volume as 40 states adopt the program, signaling a major shift in how commercial real estate projects are financed.
